HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys.

Abstract
Behavioral effects of a nonpeptidic NOP (nociceptin/orphanin FQ Peptide) receptor agonist, Ro 64-6198, have not been studied in primate species. The aim of the study was to verify the receptor mechanism underlying the behavioral effects of Ro 64-6198 and to systematically compare behavioral effects of Ro 64-6198 with those of a mu-opioid receptor agonist, alfentanil, in monkeys. Both Ro 64-6198 (0.001-0.06 mg/kg, s.c.) and alfentanil (0.001-0.06 mg/kg, s.c.) produced antinociception against an acute noxious stimulus (50 degrees C water) and capsaicin-induced allodynia. An NOP receptor antagonist, J-113397 (0.01-0.1 mg/kg, s.c.), dose-dependently produced rightward shifts of the dose-response curve of Ro 64-6198-induced antinociception. The apparent pA(2) value of J-113397 was 8.0. Antagonist studies using J-113397 and naltrexone revealed that Ro 64-6198 produced NOP receptor-mediated antinociception independent of mu-opioid receptors. In addition, alfentanil dose-dependently produced respiratory depression and itch/scratching responses, but antinociceptive doses of Ro 64-6198 did not produce such effects. More important, Ro 64-6198 did not produce reinforcing effects comparable with those of alfentanil, cocaine, or methohexital under self-administration procedures in monkeys. These results provide the first functional evidence that the activation of NOP receptors produces antinociception without reinforcing effects in primates. Non-peptidic NOP receptor agonists may have therapeutic value as novel analgesics without abuse liability in humans.
AuthorsMei-Chuan Ko, James H Woods, William E Fantegrossi, Chad M Galuska, Jürgen Wichmann, Eric P Prinssen
JournalNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (Neuropsychopharmacology) Vol. 34 Issue 9 Pg. 2088-96 (Aug 2009) ISSN: 1740-634X [Electronic] England
PMID19279568 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Analgesics, Opioid
  • Benzimidazoles
  • Central Nervous System Agents
  • Imidazoles
  • J 113397
  • Narcotic Antagonists
  • Piperidines
  • Receptors, Opioid
  • Receptors, Opioid, mu
  • Ro 64-6198
  • Spiro Compounds
  • Alfentanil
  • Naltrexone
  • Capsaicin
  • Nociceptin Receptor
Topics
  • Alfentanil (pharmacology)
  • Analgesics, Opioid (pharmacology)
  • Animals
  • Behavior, Animal (drug effects)
  • Benzimidazoles (pharmacology)
  • Capsaicin
  • Central Nervous System Agents (pharmacology)
  • Dose-Response Relationship, Drug
  • Female
  • Hot Temperature
  • Imidazoles (pharmacology)
  • Macaca mulatta
  • Male
  • Naltrexone (pharmacology)
  • Narcotic Antagonists (pharmacology)
  • Pain (chemically induced, drug therapy)
  • Piperidines (pharmacology)
  • Pruritus (drug therapy)
  • Receptors, Opioid (agonists)
  • Receptors, Opioid, mu (agonists, metabolism)
  • Reinforcement, Psychology
  • Respiratory Insufficiency (drug therapy)
  • Spiro Compounds (pharmacology)
  • Nociceptin Receptor

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: